Merck's Ebola vaccine found to be effective by expert panel

Newly-created #Ebola vaccine '100% effective' so far in tests

LONDON — Merck & Co's vaccine for Ebola is "highly effective", according to an interim analysis from a panel of experts who recommended that a late-stage trial should continue. The vaccine was 100 per cent effective when it was tested on more than 4,000 people who were in close contact with Ebola patients in the African nation of Guinea, the World Health Organization said, citing a study published today (July 31) in the Lancet medical journal. The trial of the vaccine, called Ebola ca suffit — "Ebola, that's enough" in French — began on March 23. Ebola has killed more than 11,000 people in West Africa following an outbreak at the end of 2013. While the incidence has fallen off sharply, it has not been eradicated, with seven confirmed cases in the week of July 29. The drug from Merck is one of several vaccines in clinical trials, with GlaxoSmithKline and Novavax also develo...

Full article: http://www.todayonline.com/daily-focus/health/mercks-ebol...